(Millions of yen)
|
Fiscal year ended Mar 31, 2022 |
Fiscal year ended Mar 31, 2023 |
Fiscal year ended Mar 31, 2024 |
| Eye Care |
43,102 |
48,180 |
53,402 |
| Skin Care |
124,055 |
156,657 |
176,816 |
| Internal medicines |
25,604 |
26,588 |
30,898 |
| Others |
6,884 |
7,237 |
9,722 |
| Total |
199,646 |
238,664 |
270,840 |
Notes: The Company has applied the Accounting Standard for Revenue Recognition
(ASBJ Statement No. 29, March 31, 2020), from the beginning of the current
fiscal year, and the figures for the fiscal year ended March 2022 are after
the application of the said accounting standard. The percentage changes
from the same period of the previous fiscal year are not stated.